ES8502611A1 - Antibronchospastic water-soluble pharmaceutical compositions - Google Patents

Antibronchospastic water-soluble pharmaceutical compositions

Info

Publication number
ES8502611A1
ES8502611A1 ES525280A ES525280A ES8502611A1 ES 8502611 A1 ES8502611 A1 ES 8502611A1 ES 525280 A ES525280 A ES 525280A ES 525280 A ES525280 A ES 525280A ES 8502611 A1 ES8502611 A1 ES 8502611A1
Authority
ES
Spain
Prior art keywords
antibronchospastic
water
pharmaceutical compositions
soluble pharmaceutical
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525280A
Other languages
Spanish (es)
Other versions
ES525280A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Malesci Instituto Farmacobiologico SpA
Original Assignee
Malesci Instituto Farmacobiologico SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Malesci Instituto Farmacobiologico SpA filed Critical Malesci Instituto Farmacobiologico SpA
Publication of ES8502611A1 publication Critical patent/ES8502611A1/en
Publication of ES525280A0 publication Critical patent/ES525280A0/en
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Abstract

Antibronchospastic water-soluble compositions comprise the compounds formed from theophylline and amino acids, e.g. lysin or arginine.
ES525280A 1981-06-22 1983-08-31 A PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS BASED ON THEOPHILINE SALTS AND BASIC AMINO ACIDS Granted ES525280A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48730/81A IT1171321B (en) 1981-06-22 1981-06-22 WATER-SOLUBLE ANTIBRONCOSPASTIC PHARMACEUTICAL COMPOSITIONS CONSTITUTED BY THEOPHYLLINE SALTS WITH BASIC AMINO ACIDS

Publications (2)

Publication Number Publication Date
ES8502611A1 true ES8502611A1 (en) 1985-01-16
ES525280A0 ES525280A0 (en) 1985-01-16

Family

ID=11268293

Family Applications (2)

Application Number Title Priority Date Filing Date
ES513302A Granted ES513302A0 (en) 1981-06-22 1982-06-21 "A PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS BASED ON THEOPHILINE SALTS AND BASIC AMINO ACIDS".
ES525280A Granted ES525280A0 (en) 1981-06-22 1983-08-31 A PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS BASED ON THEOPHILINE SALTS AND BASIC AMINO ACIDS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES513302A Granted ES513302A0 (en) 1981-06-22 1982-06-21 "A PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS BASED ON THEOPHILINE SALTS AND BASIC AMINO ACIDS".

Country Status (6)

Country Link
BE (1) BE893562A (en)
DE (1) DE3223485A1 (en)
ES (2) ES513302A0 (en)
FR (1) FR2507892B1 (en)
GB (1) GB2100982A (en)
IT (1) IT1171321B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0441119A3 (en) * 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB624696A (en) * 1945-09-06 1949-06-15 John Christian Krantz Improvements in or relating to method of preparing a stable aqueous theophylline solution and the product resulting therefrom
US2711409A (en) * 1951-06-07 1955-06-21 Chattanooga Medicine Co Salts of 8-halotheophylline and alkali metal salts of amino acids
FR91M (en) * 1960-07-29 1961-01-09
FR952M (en) * 1961-02-28 1961-11-20
FR2531713A2 (en) * 1981-09-16 1984-02-17 Panmedica Sa New compositions based on 5-hydroxytryptophan, process for preparing them and medicaments containing them

Also Published As

Publication number Publication date
ES8401320A1 (en) 1983-12-16
IT8148730A0 (en) 1981-06-22
BE893562A (en) 1982-10-18
DE3223485A1 (en) 1983-01-05
FR2507892A1 (en) 1982-12-24
IT1171321B (en) 1987-06-10
ES513302A0 (en) 1983-12-16
GB2100982A (en) 1983-01-12
ES525280A0 (en) 1985-01-16
FR2507892B1 (en) 1986-06-27

Similar Documents

Publication Publication Date Title
DE3262899D1 (en) Salts of valproic acid, their preparation and their use
IL86782A (en) Amino acid derivatives, processes for the preparation thereof and pharmaceutical compositions comprising the same
IL81172A0 (en) N-containing fused heterocyclic compounds,processes for the preparation thereof and pharmaceutical compositions comprising the same
ATE22562T1 (en) 6-SUBSTITUTE S-TRIAZOLO(3,4-A)PHTHALAZINE DERIVATIVES.
ES527776A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1,4-DIHIDROPIRIDINAS.
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3586697D1 (en) Aktive thymopentin-analoga.
IT8721411A0 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N ACETYLSYSTEINE.
DE3276164D1 (en) Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
IL81800A0 (en) 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo(or oxo)-5-pyrimidine-carboxylic acids and esters and pharmaceutical compositions containing the same
IE822519L (en) Phosphonic acid derivatives
IT8820935A0 (en) PROCEDURE FOR THE PREPARATION OF 1,2,5,6,9,10 HEXABROMOCYCLODECAN.
IT8322028V0 (en) JOINT FOR FURNITURE.
EP0247177A4 (en) Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses.
EP0107693A4 (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2 analogues, process for the preparation thereof and pharmaceutical compositions containing the same.
NO874888L (en) PROCEDURE FOR THE PREPARATION OF AMINOMETHYL-5,6,7,8-TETRAHYDRONAFTYLOXYDOIC ACIDS.
ES8502611A1 (en) Antibronchospastic water-soluble pharmaceutical compositions
GB2109796B (en) Anorexigenic tripeptides, process for the preparation thereof and pharmaceutical compositions containing them
IL77188A0 (en) Pharmaceutical compositions for the treatment of acquired immune deficiency syndrome and analogous syndromes
ZA824437B (en) Substituted pyrimidines,processes for their preparation and pharmaceutical compositions thereof
NL189406C (en) PROCESS FOR THE PREPARATION OF 3,3 'OR 3,4' DIAMINOBENZOPHENONE.
NO880007L (en) PROCEDURE FOR THE PREPARATION OF LIPOFILE AMINO ACID DERIVATIVES AND LIPOFILE AMINO ACID DERIVATIVES.
EP0300036A4 (en) Vasopressin-based pharmaceutical compositions.
PT86665A (en) PROCESS FOR THE PREPARATION OF 14.15-SUBSTITUTED LANOSTEROLS AND OF HYPOCHOLESTEROLEMIC COMPOSITIONS CONTAINING THE SAME